EHS
EHS

Acorda Therapeutics Announces FDA Approval of INBRIJA™ (levodopa inhalation powder)




ARDSLEY, N.Y.–(BUSINESS WIRE)–Acorda Therapeutics announces FDA approval of INBRIJA™ (levodopa inhalation powder).

Source link

EHS
Back to top button